Syngene had successfully demonstrated the small-scale synthesis of a novel vascular calcification inhibitor API from lab-scale to tox-batch manufacturing. This was following the request of a pharma ...
Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade applications, and 99.9% purity demand expansion. High purity acetic acid enables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results